Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

NCT01760005 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

490

Enrollment

OTHER

Sponsor class

Conditions

Alzheimers Disease
Dementia
Alzheimers Disease, Familial

Interventions

DRUG: Gantenerumab
DRUG: Solanezumab
DRUG: Matching Placebo (Gantenerumab)
DRUG: Matching Placebo (Solanezumab)
DRUG: Gantenerumab
DRUG: E2814
DRUG: Lecanemab
DRUG: Matching Placebo (E2814)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]